Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APRI

Apricus Biosciences (APRI) Stock Price, News & Analysis

Apricus Biosciences logo

About Apricus Biosciences Stock (NASDAQ:APRI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2 shs
Average Volume
558,386 shs
Market Capitalization
$14 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apricus Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APRI Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

APRI Stock Analysis - Frequently Asked Questions

Apricus Biosciences, Inc. (NASDAQ:APRI) posted its quarterly earnings results on Wednesday, October, 31st. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apricus Biosciences investors own include Scotts Miracle-Gro (SMG), Pfizer (PFE), Just Eat Takeaway.com (GRUB), Boston Beer (SAM), Amicus Therapeutics (FOLD), Palatin Technologies (PTN) and Synergy Pharmaceuticals (SGYP).

Company Calendar

Last Earnings
10/31/2018
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APRI
CIK
1017491
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$320 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-216.45%
Return on Assets
-153.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.86
Quick Ratio
3.86

Sales & Book Value

Annual Sales
$5.76 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,170,000
Free Float
N/A
Market Cap
$14 thousand
Optionable
Not Optionable
Beta
1.20
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:APRI) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners